Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
Cybin
Cybin Raises $30 Million Through Underwritten Offering
November
16
,
2023
Cybin Psilocybin Phase 2 Trial Shows Significant Reduction in Depressive Symptoms
November
3
,
2023
1
2
3